Literature DB >> 31425903

Longitudinal brain atrophy patterns and neuropsychological performance in older adults with HIV-associated neurocognitive disorder compared with early Alzheimer's disease.

Benedetta Milanini1, Vishal Samboju2, Yann Cobigo2, Robert Paul3, Shireen Javandel2, Joanna Hellmuth2, Isabel Allen4, Bruce Miller2, Victor Valcour2.   

Abstract

Older HIV-infected patients are at risk for both HIV-associated neurocognitive disorder (HAND) and Alzheimer's disease. We investigated neuroimaging and neuropsychological performance of 61 virally suppressed older adults with HAND (mean (SD) age 64.3 (3.9) years), 53 demographically matched individuals with mild cognitive impairment of the Alzheimer's type (MCI-AD; 65.0 [4.8]), and 89 healthy controls (65.0 [4.3]) cross-sectionally and over 20 months. At the baseline, both disease groups exhibited lower volumes in multiple cortical and subcortical regions compared with controls. Hippocampal volume differentiated MCI-AD from HAND. Cognitively, MCI-AD performed worse on memory and language compared with HAND. Adjusted longitudinal models revealed greater diffuse brain atrophy in MCI-AD compared with controls, whereas HAND showed greater atrophy in frontal gray matter and cerebellum compared with controls. Comparing HAND with MCI-AD showed similar atrophy rates in all brain regions explored, with no significant findings. MCI-AD exhibited more pronounced language decline compared with HAND. These findings reveal the need for further work on unique cognitive phenotypes and neuroimaging signatures of HAND compared with early AD, providing preliminary clinical insight for differential diagnosis of age-related brain dysfunction in geriatric neuroHIV.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer disease; Cognitive dysfunction; HIV; Mild cognitive impairment; Neuroimaging

Mesh:

Year:  2019        PMID: 31425903      PMCID: PMC6823146          DOI: 10.1016/j.neurobiolaging.2019.07.006

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  58 in total

1.  Association of Brain Structure Changes and Cognitive Function With Combination Antiretroviral Therapy in HIV-Positive Individuals.

Authors:  Ryan Sanford; Lesley K Fellows; Beau M Ances; D Louis Collins
Journal:  JAMA Neurol       Date:  2018-01-01       Impact factor: 18.302

2.  Accelerated and Premature Aging Characterizing Regional Cortical Volume Loss in Human Immunodeficiency Virus Infection: Contributions From Alcohol, Substance Use, and Hepatitis C Coinfection.

Authors:  Adolf Pfefferbaum; Natalie M Zahr; Stephanie A Sassoon; Dongjin Kwon; Kilian M Pohl; Edith V Sullivan
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2018-07-04

3.  Hippocampal atrophy and ventricular enlargement in normal aging, mild cognitive impairment (MCI), and Alzheimer Disease.

Authors:  Liana G Apostolova; Amity E Green; Sona Babakchanian; Kristy S Hwang; Yi-Yu Chou; Arthur W Toga; Paul M Thompson
Journal:  Alzheimer Dis Assoc Disord       Date:  2012 Jan-Mar       Impact factor: 2.703

4.  HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study.

Authors:  R K Heaton; D B Clifford; D R Franklin; S P Woods; C Ake; F Vaida; R J Ellis; S L Letendre; T D Marcotte; J H Atkinson; M Rivera-Mindt; O R Vigil; M J Taylor; A C Collier; C M Marra; B B Gelman; J C McArthur; S Morgello; D M Simpson; J A McCutchan; I Abramson; A Gamst; C Fennema-Notestine; T L Jernigan; J Wong; I Grant
Journal:  Neurology       Date:  2010-12-07       Impact factor: 9.910

5.  Mapping white matter integrity in elderly people with HIV.

Authors:  Talia M Nir; Neda Jahanshad; Edgar Busovaca; Lauren Wendelken; Krista Nicolas; Paul M Thompson; Victor G Valcour
Journal:  Hum Brain Mapp       Date:  2013-01-30       Impact factor: 5.038

6.  Brain structural correlates of trajectories to cognitive impairment in men with and without HIV disease.

Authors:  Mikhail Popov; Samantha A Molsberry; Fabrizio Lecci; Brian Junker; Lawrence A Kingsley; Andrew Levine; Eileen Martin; Eric Miller; Cynthia A Munro; Ann Ragin; Eric Seaberg; Ned Sacktor; James T Becker
Journal:  Brain Imaging Behav       Date:  2020-06       Impact factor: 3.978

7.  Neurocognitive consequences of HIV infection in older adults: an evaluation of the "cortical" hypothesis.

Authors:  J Cobb Scott; Steven Paul Woods; Catherine L Carey; Erica Weber; Mark W Bondi; Igor Grant
Journal:  AIDS Behav       Date:  2011-08

8.  The cerebrospinal fluid biomarker profile in an HIV-infected subject with Alzheimer's disease.

Authors:  Signar Mäkitalo; Åsa Mellgren; Ellen Borgh; Lena Kilander; Tobias Skillbäck; Henrik Zetterberg; Magnus Gisslén
Journal:  AIDS Res Ther       Date:  2015-07-14       Impact factor: 2.250

9.  An individual with human immunodeficiency virus, dementia, and central nervous system amyloid deposition.

Authors:  Raymond Scott Turner; Melanie Chadwick; Wesley A Horton; Gary L Simon; Xiong Jiang; Giuseppe Esposito
Journal:  Alzheimers Dement (Amst)       Date:  2016-04-15

10.  MRI markers for mild cognitive impairment: comparisons between white matter integrity and gray matter volume measurements.

Authors:  Yu Zhang; Norbert Schuff; Monica Camacho; Linda L Chao; Thomas P Fletcher; Kristine Yaffe; Susan C Woolley; Catherine Madison; Howard J Rosen; Bruce L Miller; Michael W Weiner
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

View more
  9 in total

Review 1.  Bromodomains in Human-Immunodeficiency Virus-Associated Neurocognitive Disorders: A Model of Ferroptosis-Induced Neurodegeneration.

Authors:  Adonis Sfera; Karina G Thomas; Christina V Andronescu; Nyla Jafri; Dan O Sfera; Sarvin Sasannia; Carlos M Zapata-Martín Del Campo; Jose C Maldonado
Journal:  Front Neurosci       Date:  2022-05-12       Impact factor: 5.152

2.  Alzheimer Dementia in People Living With HIV.

Authors:  Andrea Calcagno; Luigi Celani; Mattia Trunfio; Giancarlo Orofino; Daniele Imperiale; Cristiana Atzori; Vincenzo Arena; Gabriella d'Ettorre; Giovanni Guaraldi; Magnus Gisslen; Giovanni Di Perri
Journal:  Neurol Clin Pract       Date:  2021-10

3.  Alzheimer Disease and HIV: Untangling the Gordian Knot.

Authors:  Lambros Messinis; Grigorios Nasios
Journal:  Neurol Clin Pract       Date:  2021-10

4.  Cognitive and motor deficits in older adults with HIV infection: Comparison with normal ageing and Parkinson's disease.

Authors:  Eva M Müller-Oehring; Rosemary Fama; Taylor F Levine; Cheshire Hardcastle; Ryan Goodcase; Talora Martin; Varsha Prabhakar; Helen M Brontë-Stewart; Kathleen L Poston; Edith V Sullivan; Tilman Schulte
Journal:  J Neuropsychol       Date:  2020-10-08       Impact factor: 2.864

5.  Early prediction of putamen imaging features in HIV-associated neurocognitive impairment syndrome.

Authors:  Yu Qi; Man Xu; Wei Wang; Yuan-Yuan Wang; Jiao-Jiao Liu; Hai-Xia Ren; Ming-Ming Liu; Rui-Li Li; Hong-Jun Li
Journal:  BMC Neurol       Date:  2021-03-09       Impact factor: 2.474

Review 6.  Central Nervous System Effects of COVID-19 in People with HIV Infection.

Authors:  Michael J Peluso; Joanna Hellmuth; Felicia C Chow
Journal:  Curr HIV/AIDS Rep       Date:  2021-11-29       Impact factor: 5.071

7.  Intestinal Flora Balance Therapy Based on Probiotic Support Improves Cognitive Function and Symptoms in Patients with Alzheimer's Disease: A Systematic Review and Meta-analysis.

Authors:  Changxing Liu; Xinyi Guo; Xiang Chang
Journal:  Biomed Res Int       Date:  2022-08-16       Impact factor: 3.246

8.  Enhancing cue salience improves aspects of naturalistic time-based prospective memory in older adults with HIV disease.

Authors:  Steven Paul Woods; Erin E Morgan; Shayne Loft; Anastasia Matchanova; Marizela Verduzco; Clint Cushman
Journal:  Neuropsychology       Date:  2021-01       Impact factor: 3.295

9.  Cerebrovascular Disease Correlates With Longitudinal Brain Atrophy in Virally Suppressed Older People Living With HIV.

Authors:  Vishal Samboju; Yann Cobigo; Robert Paul; Georges Naasan; Madeline Hillis; Torie Tsuei; Shireen Javandel; Victor Valcour; Benedetta Milanini
Journal:  J Acquir Immune Defic Syndr       Date:  2021-08-01       Impact factor: 3.771

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.